Both platforms have grown significantlytelehealth GLP-1 prescriptions increased approximately 40% year-over-year through 2024but their underlying supply chains, clinical protocols, and integration of genetic insights differ meaningfully
Listen to your bodys signals
High Costs & Systemic Barriers Exacerbate Health Inequities Policy Reforms Are Critical to Address Structural Inequities High Costs and Systemic Barriers Exacerbate Health Inequities: The products Ozempic, Rybelsus, and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide) are priced at roughly $1,000 per month
If youre looking for safe and legitimate weight loss treatment thatll actually work, its better to choose regulated, prescription options
should not be mistaken for a change in that picture
doi:10.1093/humupd/dmz027